Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
Fertility and Sterility|October 31, 1998
Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatmentT Eldar-Geva, S Meagher, D L Healy, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1986
Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phaseD L Healy, S R Lawson, M Abbott, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1977
Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testingD L Healy, R J Pepperell, J Stockdale, et al.
The American Journal of Physiology|January 1, 1980
Prolactin in human milk: correlation with lactose, total protein, and alpha-lactalbumin levelsD L Healy, S Rattigan, P E Hartmann, et al.
Biochimica Et Biophysica Acta|March 4, 2000
Measurements of the dielectric properties of peripheral blood mononuclear cells and trophoblast cells using AC electrokinetic techniquesK L Chan, H Morgan, E Morgan, et al.
Molecular Human Reproduction|January 1, 1997
Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometriumJ F Telfer, G A Irvine, G Kohnen, et al.
Molecular Human Reproduction|October 27, 2004
Progesterone inhibits insulin-like growth factor binding protein-1 (IGFBP-1) production by explants of the Fallopian tubeS Davies, M C Richardson, F W Anthony, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 16, 2000
The long term health consequences of polycystic ovary syndromeC J Kelly, J M Connell, I T Cameron, et al.
Obstetrics and Gynecology|July 1, 1990
The effects of mefenamic acid and norethisterone on measured menstrual blood lossI T Cameron, R Haining, M A Lumsden, et al.
Human Reproduction (Oxford, England)|March 1, 1995
Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatmentA M Suikkari, V MacLachlan, J Montalto, et al.
Pageof 20